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Abstract
Polymers or hydrogels containing modified cyclodextrin (CD) are highly useful in drug delivery 
applications as CD is a cytocompatible amphiphilic molecule that can complex with a variety of 
hydrophobic drugs. Here, we designed modular photo-click thiol-ene hydrogels from derivatives 
of βCD and poly(ethylene glycol) (PEG), including βCD-allylether (βCD-AE), βCD-thiol (βCD-
SH), PEG-thiol (PEGSH), and PEG-norbornene (PEGNB). Two types of CD-PEG hybrid 
hydrogels were prepared using radical-mediated thiol-ene photo-click reactions. Specifically, thiol-
allylether hydrogels were formed by reacting multi-arm PEGSH and βCD-AE, and thiol-
norbornene hydrogels were formed by cross-linking βCD-SH and multi-arm PEGNB. We 
characterized the properties of these two types of thiol-ene hydrogels, including gelation kinetics, 
gel fractions, hydrolytic stability, and cytocompatibility. Compared with thiol-allylether hydrogels, 
thiol-norbornene photo-click reaction formed hydrogels with faster gelation kinetics at equivalent 
macromer contents. Using curcumin, an anti-inflammatory and anti-cancer hydrophobic molecule, 
we demonstrated that CD-crosslinked PEG-based hydrogels, when compared with pure PEG-
based hydrogels, afforded higher drug loading efficiency and prolonged delivery in vitro. 
Cytocompatibility of these CD-crosslinked hydrogels were evaluated by in situ encapsulation of 
radical sensitive pancreatic MIN6 β-cells. All formulations and crosslinking conditions tested 
were cytocompatible for cell encapsulation. Furthermore, hydrogels crosslinked by βCD-SH 
showed enhanced cell proliferation and insulin secretion as compared to gels crosslinked by either 
dithiothreitol (DTT) or βCD-AE, suggesting the profound impact of both macromer compositions 
and gelation chemistry on cell fate in chemically crosslinked hydrogels.
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Introduction
As defined by the Food and Drug Administration (FDA), amphiphilic cyclodextrins (CDs) 
are a class of ‘Generally Recognized as Safe (GRAS)’ macromolecules 1-3. The hydrophobic 
cavity of CD can accommodate a broad range of poorly soluble drugs through host-guest 
complex formation, whereas the hydrophilic surface of CD facilitates the dissolution of the 
CD-drug complex in aqueous solutions 4. Three types of CD, α-, β-, and γ-CD (with 6, 7, 
and 8 repeating units of glycopyranose, respectively), are commonly used for increasing the 
solubility of hydrophobic drugs 5. In addition to serving as a drug-dissolving agent, CDs can 
be easily modified for forming multifunctional macromolecules, including linear polymers 
and network hydrogels 6-8. For example, hydroxyl groups of βCD could be functionalized 
with acrylate for crosslinking into hydrogel for binding and releasing anti-cancer drug, such 
as chlorambucil. The release rate was controlled by adjusting pH or degree of network 
crosslinking 9. CD could also be functionalized with azide for chemical crosslinking with 
PEG-di-alkyne via the copper-catalyzed azide-alkyne cycloaddition (CuAAC) 10. 
Unfortunately, copper is a cytotoxic metal that induces oxidative damage to cells 11. Hence, 
CuAAC is mostly not compatible with live cell experiments 12. Recently, Sanyal et al. 
reported the formation and characterization of Michael-type thiol-maleimide hydrogels 
using hepta-thiol-substituted βCD (βCD-SH7) and linear poly(ethylene glycol)-maleimide 
(PEG-maleimide) 13. However, maleimide group deprives topoisomerase II catalytic activity 
of cells that can lead to cell apoptosis 14 and the presence of unreacted maleimide might 
create adverse effects on cell viability 14, 15. In addition, thiol-maleimide gelation proceeds 
via a nucleophilic reaction that does not allow one to easily control polymerization kinetics. 
In this regard, Arslan et al. prepared CD-PEG hybrid hydrogels through photo-crosslinking 
of commercially available βCD-SH7 and PEG-allylether and the hydrogels were used to 
deliver hydrophobic puerarin 16. This hydrogel crosslinking, however, was carried out in an 
organic condition using dimethylformamide (DMF) as the solvent. As a result, this system 
was not compatible for in situ cell encapsulation.
In the past few years, we and other groups have explored the aqueous-based step-growth 
thiol-norbornene photo-click chemistry to prepare highly cytocompatible and tunable 
hydrogels for tissue engineering applications 17. The gelation of thiol-norbornene hydrogels 
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can be initiated by type I photoinitiator (e.g., Irgacure-2959 or lithium arylphosphinate 
(LAP)) under long wavelength, low intensity ultraviolet (UV) light irradiation (365 nm, 5–
10 mW/cm2). Thiol-norbornene gelation could also be initiated by visible light (400-700 
nm) exposure with type II photoinitiator (e.g., eosin-Y or rose bengal) as the sole 
photosensitizer 18, 19. The advantages of step-growth thiol-norbornene photopolymerization 
include rapid, ambient, and aqueous reaction conditions, as well as spatial-temporal control 
over gelation kinetics 20-22. More importantly, thiol-norbornene hydrogels are highly 
cytocompatible even for radical-sensitive pancreatic β-cells 23, 24. In addition to PEG-
norbornene, other macromers containing non-homopolymerizable ‘ene’ moieties have been 
explored for forming step-growth thiol-ene hydrogels. For example, Kloxin and colleagues 
recently reported an aqueous thiol-allylether reaction to form thiol-ene hydrogel for in situ 
cell encapsulation. The radical-mediated thiol-allylether hydrogel was formed between 
multi-arm PEG-thiol (PEGSH) and bis-allyloxycarbonyl functionalized peptides 25. This 
thiol-allylether gelation produced hydrolytically stable hydrogels that were cytocompatible 
for encapsulation of human mesenchymal stem cells (hMSCs).
Thiol-ene hydrogels have been exploited as platforms for encapsulating hydrophilic 
biomolecules, drugs, and cells. Since CDs are capable of increasing the solubility of poorly 
soluble molecules, a CD-crosslinked thiol-ene hydrogel can potentially be used to 
encapsulate and to deliver both hydrophilic and hydrophobic biomolecules. Furthermore, 
CD can be used to form supramolecular association with selected hydrophobic molecules or 
drugs, such as adamantane and curcumin. A CD-immobilized hydrogel formed by the 
aqueous thiol-ene photo-click reaction will not only permit in situ cell encapsulation, but 
may also allow researchers to create hydrogels with dynamically tunable properties in the 
presence of cells. As the first step toward achieving this goal, we report here the synthesis 
and characterization of βCD derivatives, the crosslinking of βCD-PEG hybrid hydrogels via 
radical-mediated thiol-ene photopolymerizations, the delivery of a model hydrophobic drug, 
and the cytocompatibility of these step-growth hydrogels. Specifically, a two-step synthesis 
procedure was developed for functionalizing βCD with the desired number of allylether, 
which could be used to form hydrolytically stable thiol-allylether photo-click hydrogel. 
Alternatively, allylether moieties could be further converted to thiols, which could be used to 
form thiol-norbornene hydrogels. Both thiol-ene gelation systems utilized a low 
concentration of LAP as the photoinitiator and the gelation was initiated via light exposure 
at 365 nm. We investigated the gelation kinetics and physical properties of these two types 
of thiol-ene hydrogels. Curcumin, a hydrophobic molecule with anti-inflammatory and anti-
cancer potential, was used as a model drug to demonstrate the enhanced uptake and 
prolonged release of hydrophobic drug from CD-crosslinked thiol-ene hydrogels. 
Furthermore, the cytocompatibility of these step-growth CD-crosslinked thiol-ene hydrogels 
were evaluated via in situ encapsulation of radical-sensitive pancreatic MIN6 β-cells.
Materials and Methods
Materials
4-arm PEG (20 kDa), 8-arm PEG (20 kDa and 40 kDa) and 8-arm PEG-thiol (PEG8SH, 20 
kDa) were purchased from JenKem Technology USA. βCD was purchased from TCI 
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America. 5-norbornene-2-carboxylic acid, N,N′-dicyclohexylcarbodiimide (DCC), 4-
(dimethylamino) pyridine (DMAP), sodium hydride, and allyl bromide were obtained from 
Sigma-Aldrich. Dialysis membranes with MWCO 500-1000 Da and 6000-8000 Da were 
obtained from Spectrum Laboratories and Fisher Scientific, respectively. Other chemicals 
were purchased from Fisher Scientific unless noted otherwise.
Synthesis of photoinitiator and PEG macromers
The synthesis of photoinitiator lithium arylphosphonate (LAP) was described as reported 
elsewhere 26. PEG-tetra-norbornene (PEG4NB, 20 kDa) and PEG-octa-norbornene 
(PEG8NB, 20 kDa and 40 kDa) were synthesized following an established protocol 20. In 
brief, 5-norbornene-2-carboxylic acid (5-fold excess of OH group) and coupling reagent 
DCC (2.5-fold excess of OH group) were added to anhydrous dichloromethane (DCM). The 
mixture was purged with nitrogen and stirred at room temperature for 1 hour. The resulting 
norbornene anhydride was filtered into an addition funnel and added slowly to a flask 
containing PEG (4-arm or 8-arm), DMAP (0.5-fold of OH group), and pyridine (0.5-fold of 
OH group) dissolved in anhydrous DCM. The flask was purged with nitrogen, kept on ice 
and allowed to react overnight in dark. The product was precipitated in cold ethyl ether and 
collected by filtration. PEGNB product was re-dissolved in double distilled water (ddH2O) 
and proceed with dialysis (MWCO 6000-8000 Da) for 2 days using slightly acidic ddH2O 
(pH 6.8) to prevent ester hydrolysis of PEGNB. The pure product was obtained from 
lyophilization (degree of norbornene substitution >85 %). PEGNB: 1H NMR (CDCl3, 500 
MHz): δ – 4.25 (m, 2H), 5.98 (m, 1H), 6.23 (m, 1H). PEG-allylether (PEGAE) was 
synthesized following a published protocol. Briefly, linear PEG (3.4 kDa) was dissolved in 
anhydrous toluene and dried with evaporation by reduced pressure. Dried PEG was re-
dissolved in anhydrous tetrahydrofuran (THF). Sodium hydride (1.5-fold excess of hydroxyl 
group) was added slowly to the PEG solution under continuous nitrogen purging at 40 °C. 
Upon complete liberation of hydrogen gas, allylbromide (6-fold excess of hydroxyl group) 
was added drop wise to the solution. After overnight reaction in dark, sodium bromide salt 
was filtered off to afford a PEG-allylether (PEGAE) solution. PEGAE was precipitated in 
cold ethyl ether, filtered and dried in vacuuo. The purity of PEGAE product was verified 
with H1 NMR in CDCl3 (96 %, Bruker 500). PEGAE: 1H NMR (CDCl3, 500 MHz): δ – 
4.04 (m, 2H), 5.31 (m, 1H), 5.43 (m, 1H), 6.07 (m, 1H).
Synthesis of allylether or thiol functionalized βCD
βCD-AE was synthesized following a published protocol with slight modification 27. βCD 
was dried in vacuum oven overnight and dissolved in 40 mL of anhydrous 
dimethylformamide (DMF) in a flask. While purging the flask with nitrogen, desired amount 
of sodium hydride (i.e., 2.3, 4.5 or 11.3-fold of [NaH] and [allylbromide] to [βCD]) was 
added slowly and the mixture was stirred until no hydrogen gas bubbles were visible (Figure 
1A, step i). Allylbromide (Figure S1A) was added drop wise to the βCD solution using an 
addition funnel and the reaction was allowed to continue overnight in dark (Figure 1A, step 
ii). Next, the volume of βCD-AE mixture was reduced using a rotary evaporator. βCD-AE 
was precipitated in cold acetone twice and dried in a vacuum oven. βCD-AE: 1H NMR 
((CD3)2SO, 500 MHz): δ – 4.04 (m, 2H), 5.31 (m, 1H), 5.43 (m, 1H), 6.07 (m, 1H). The 
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exact mass of βCD-AE was determined by using mass spectroscopy (Agilent Technologies 
6520 Accurate-Mass Q-TOF LC/MS).
Next, thioacetic acid (Figure S1B, 2-fold excess to [βCD-AE]) was added slowly to 10 mL 
of DMF containing 1 g of βCD-AE and photoinitiator Irgacure I-2959 (0.5 wt%). Photo-
conjugation was initiated by UV-light exposure (Omicure S1000, 365 nm and 10 mW/cm2) 
for 15 minutes and continued for another 30 minutes after supplementing with another 
portion of 0.5 wt% I-2959 (Figure 1A, step iii). βCD-thiolacetate (Figure S1C) was 
precipitated in cold acetone, filtered, and dried in vacuum oven. After re-dissolving βCD-
thioacetate in ddH2O (10 mL), while purging with nitrogen, 5 mL of sodium hydroxide (2 
N) was added to the solution for 5 minutes to hydrolyze the thioacetate group. The solution 
was neutralized by adding equal volume of hydrochloride acid (2 N) solution, followed by 
dialysis (MWCO 500-1000) for 2 days at room temperature (Figure 1A, step iv). The 
product βCD-thiol (βCD-SH) was obtained from lyophilization. βCD-SH: 1H NMR 
((CD3)2SO, 500 MHz): δ – 1.3 (s, 1H), 1.76 (m, 2H), 2.53 (m, 2H), 3.35 (m, 2H). Ellman's 
assay was performed to determine the concentration of thiol in βCD-SH solution.
Hydrogel fabrication and characterizations
Step-growth thiol-ene hydrogels were formed by light mediated photo-click reactions using 
the following macromers: (1) PEG8SH (20 kDa) and βCD-AE, (2) PEG8NB (20 kDa) and 
βCD-SH, or (3) PEG8NB (20 kDa) and DTT. To obtain the best crosslinking efficiency in 
each gelation formulation, the stoichiometric ratio of thiol to ene was maintained at one. The 
concentration of PEGNB was adjusted based on 1H NMR results to afford correct 
norbornene concentrations in the gelation mixtures. Photoinitiator LAP was added to the 
precursor solution (50 μL/gel) to afford a final concentration of 1 mM. The precursor 
solution was injected in between two glass slides separated by 1 mm thick spacers. Hydrogel 
slabs were prepared by exposing the solution to 365 nm light at 5 mW/cm2 for 5 minutes. To 
characterize gel fractions, hydrogels were immediately dried in vacuuo after gelation. Dry 
mass (WDry,1) was measured and the dried polymers were incubated in ddH2O at 37 °C on 
an orbital shaker for 24 hours to remove uncrosslinked (sol fraction) species. The swollen 
gels were dried again in vacuuo and weighed to obtain dried polymer weights (WDry,2). 
After swelling hydrogels in pH 7.4 PBS for two days, the swollen gel weights were 
measured (WSwollen). Gel fractions were obtained by the ratio of the two dry masses (i.e., 
WDry,1/WDry,2). Hydrogel swelling ratios (q) were defined as the ratio of swollen gel mass to 
the second dried polymer mass (i.e., WSwollen/WDry,2).
Crosslinking efficiency of thiol-ene hydrogel
The average molecular weights between crosslinks ( ) of thiol-ene hydrogels can be 
obtained from the structural information of the macromers (i.e., molecular weight and 
functionality) 28:
(3)
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Here, MWA and MWB represent the molecular weight of PEGNB and βCD-SH, while fA 
and fB are the number of reactive functionality for PEGNB and βCD-SH, respectively. With 
a known , the ideal network crosslinking density or density of elastically active chains 
(vc) and polymer volume fraction (v2) can be calculated 29:
(4)
Here,  is the specific volume of PEG (0.92 cm3/g at 37 °C), V1 is the molar volume of 
water (18 cm3/mole) and χ12 is the Flory-Huggins interaction parameter for a PEG-H2O 
system (0.45).
In situ photo-rheometry was performed at room temperature on a Bohlin CVO 100 digital 
rheometer equipped with a light cure cell. A macromer solution (100 μL) was placed on a 
quartz plate in the light cure cell and irradiated with light (Omnicure S1000, 365 nm, 10 
mW/cm2) through a flexible light guide. Light was turned on 30 seconds after starting time-
sweep measurement (10 % strain, 1 Hz frequency, and a gap size of 90 μm) using a 25 mm 
parallel plate geometry. Gel points (i.e., crossover time) were determined at the time when 
storage modulus (G′) surpassed loss modulus (G″).
Oscillatory rheometry in strain-sweep mode was used to obtain elastic modulus of the 
hydrogel. At equilibrium swelling (after 48 hours in pH 7.4 PBS), a biopsy punch was used 
to punch out circular gel discs (8 mm in diameter) from the gel slabs. Storage moduli of the 
hydrogels were measured using 8 mm parallel plate geometry with a gap size of 800 μm. 
The elastic moduli from at least three hydrogels for each gel formulation were recorded 
from the average of the linear viscoelastic region (LVR, linear portion of G′ plotting against 
% strain).
Uptake and release of curcumin
Thiol-ene hydrogel discs (25 μL; 4.8 mm dia. × 1.1 mm height) were formed as described 
above using the following formulations: (1) PEG8SH (20 kDa) and βCD-AE, or (2) 
PEG8SH (20 kDa) and PEGAE (3.4 kDa). After photo-crosslinking, hydrogels were 
incubated in 2 mL of curcumin suspended in ddH2O (2 mg/mL). After 8 hours, hydrogels 
were removed from the curcumin suspension, rinsed with ddH2O, and placed individually in 
1.6 mL tube. Hydrogels were individually incubated in 500 μL of DMSO. A portion of 
DMSO (200 μL) was collected and fresh DMSO (200 μL) was added every 24 hours for one 
week. The amount of released curcumin in DMSO was characterized via measuring 
absorbance at 430 nm using a microplate reader (BioTek®, Synergy HT).
In another experiment, hydrogels were transferred to 4 mL scintillation vials containing 400 
μL of curcumin solution, which was prepared by dissolving curcumin in 0.5 N sodium 
hydroxide, followed by dilution with pH 7.4 PBS to a final concentration of 2 mg/mL 30. 
After incubating the gels at room temperature for 36 hours, hydrogels were transferred to 
scintillation vials containing 400 μL of pH 7.4 PBS to rinse off the curcumin adsorbed on 
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gel surface for 10 minutes. The solution was removed from the vials and 1 mL of pH 7.4 
PBS was added to each vial for curcumin release study. Scintillation vials containing 
hydrogels were placed on an orbital shaker (60 rpm) at room temperature. At specific time 
points, 500 μL of solution was collected from each vial, and fresh 500 μL of pH 7.4 PBS 
was added back to the vial. After 48 hours, PBS was completely removed from the vials, and 
1 mL of DMSO was added to each hydrogel to extract the remaining curcumin from the 
gels. At specific time points, 500 μL of DMSO was collected from each vial, and fresh 
DMSO was added back to the vial to maintain the total volume at 1 mL. The absorbance of 
all collected curcumin samples (from curcumin release and DMSO, 200 μL/sample) were 
measured using a microplate reader (BioTek®, Synergy HT) at 430 nm. Measured 
absorbance was blanked with either pH 7.4 PBS or DMSO, and correlated to standard curves 
with known concentrations of curcumin. The cumulative uptake of curcumin per gel was the 
sum of curcumin released in PBS and DMSO.
Cell encapsulation and viability assay
Mouse insulinoma cells (MIN6, final cell density in the gels at 2×106 cells/mL) were 
suspended in polymer solutions containing 1 mM LAP and macromers, including: (1) 
PEG8NB20kDa with DTT, (2) PEG8NB20kDa with βCD-SH or (3) PEG8SH20kDa with βCD-
AE. Precursor solution was exposed to light (365 nm, 5 mW/cm2) for 5 minutes to obtain 
cell-laden hydrogels (25 μl/gel), which were maintained in high-glucose DMEM 
supplemented with 10 % fetal bovine serum (FBS), 50 μM β-mercaptoethanol, and 1× 
antibiotic-antimycotic. To characterize cell viability, cell-laden hydrogels were incubated in 
500 μL Almarblue® reagent (10 % in cell culture medium) at 37 °C and 5 % of CO2. After 
14 hours of incubation, 200 μl of media were transferred to a 96-well plate for fluorescence 
quantification (excitation: 560 nm and emission: 590 nm). To obtain qualitative cell viability, 
cells were stained with a live/dead staining kit (Calcein AM stained live cells green and 
Edithium homodimer stained dead cells red) and imaged with confocal microscopy. In each 
stained hydrogel, three images were taken at a step size of 10 μm for a total depth of 100 μm 
per image. The viability of MIN6 cells was quantified as the percent of live cells over the 
total number of live and dead cells.
Insulin secretion from MIN6 cells
Cell function was assayed by glucose stimulated insulin secretion (GSIS). Briefly, cell-laden 
hydrogels were rinsed with HBSS, followed by priming in Krebs-Ringer bicarbonate (KRB) 
buffer (23 mM sodium chloride, 1 mM potassium chloride, 4.8 mM sodium bicarbonate, 0.2 
mM magnesium chloride hexahydrate, 0.2 mM calcium chloride dehydrate, 0.5 mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid and 0.1 vol% bovine serum albumin) 
containing 2.5 mM glucose for 1 hour at 37 °C and 5 % CO2. Then, the gels were incubated 
with 500 μL of low (2.5 mM) or high (25 mM) glucose KRB for 2 hours each. The high 
glucose buffer solution was collected and subjected to insulin ELISA (Mercodia).
Data analysis & statistics
All experiments were conducted independently for three times and results were reported as 
mean ± SD. Data was analyzed with student's t-test or two-way ANOVA analysis using 
GraphPad Prism 5.
Shih and Lin Page 7
Biomacromolecules. Author manuscript; available in PMC 2017 May 31.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Results and Discussion
Preparation and characterization of βCD derivatives
A two-step process was employed to modify βCD with allylether moiety. First, NaH was 
added at different concentrations to activate hydroxyl groups on βCD (Figure 1A, step i). 
Following the secession of hydrogen gas, excess allyl bromide was added to the reaction 
mixture (Figure 1A, step ii) to afford βCD-AE. 1H NMR results (Figure 1B) showed that 
allylether group was successfully introduced to βCD. Unexpected peaks between 4.1 to 4.3 
ppm were likely due to regioisomerism. Peaks of similar intensities (i.e., 3.8 or 4.6 ppm) 
were likely due to the shifting of protons on βCD as a result of allylether substitutions. The 
modification was confirmed by mass spectroscopy analysis. The difference of the average 
molecular mass of βCD-AE and βCD was divided by the molecular mass of allylether (i.e., 
40 Da) to estimate the degree of allylether functionalization. As the concentration of NaH or 
allylbromide to βCD was increased (from 0 to 11.3-fold, Figure S1), so was the detected 
mass of the modified βCD and the estimated degree of substitution (0, 1.5, 2.4 and 4.5, 
respectively). To obtain thiol-substituted βCD, βCD-AE was first photoconjugated with 
thioacetic acid via radical-mediated thiol-allylether addition (Figure 1A, step iii). The 
intermediate product, βCD-thioacetate, was hydrolyzed with sodium hydroxide, neutralized 
with hydrochloric acid, and purified via dialysis to obtain the final product, βCD-SH (Figure 
1A, step iv). 1H NMR results confirmed that allylether was replaced with thiol group (Figure 
1B, bottom panel). The presence of thiol on modified βCD was further quantified by 
Ellman's assay (Figure S2). As the concentration of βCD-SH was increased from 0.02 to 1 
mg/mL, the concentration of thiol detected increased linearly (R2 = 0.99) from 0.006 
± 0.001 to 0.362 ± 0.005 mM. As expected, no thiol was detected from unmodified βCD or 
βCD-AE.
Preparation of thiol-ene photo-click hydrogels
We next demonstrated the crosslinking of CD-PEG hybrid hydrogels using PEG8SH (M.W. 
20 kDa) and βCD-AE through a radical-mediated thiol-allylether photo-click reaction 
(Figure 2A) and the gelation was evaluated via in situ photorheometry (Figure 2B, S3). 
Specifically, 5 wt% of PEG8SH was cross-linked with different concentrations of βCD-AE 
(9 to 24 mg/mL). The gel points of all formulations evaluated were similar regardless of 
βCD-AE concentration in the precursor solution (gel point ∼ 17 to 22 seconds, Figure S3). 
However, the formulation afforded the highest elastic modulus (∼2.5 kPa at 300 second) at 
24 mg/mL of βCD-AE (Figure 2B). Further increasing βCD-AE concentration did not yield 
higher gel modulus (data not shown). Controlled experiment using unmodified βCD with 
PEG8SH showed no sign of gelation even after 300 seconds of light exposure in the 
presence of photoinitiator (Figure 2C), suggesting that the gelation was not due to disulfide 
bond formation. Since 24 mg/mL of βCD-AE yielded the highest shear modulus of thiol-
allylether hydrogel, we examined the gelation of thiol-norbornene hydrogel (Figure 2D) 
using this concentration (24 mg/mL) of thiol-substituted βCD (i.e., βCD-SH) and 5 wt% of 
8-arm PEG-norbornene (PEG8NB, M.W. 20 kDa). Even with slightly lower degree of 
functionalization (∼85 % on PEG8NB), the gelation of βCD-SH with PEG8NB still afforded 
a 5-fold faster gel point (Figure 2E, gel point ∼3 seconds). However, the final shear modulus 
of thiol-norbornene hydrogel formed with βCD-SH and PEG8NB only reached about 1.1 
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kPa (Figure 2E). Control experiment showed that gelation was not possible when 
unmodified βCD was mixed with PEG8NB (Figure 2F) and subjected to the same radical-
initiation conditions, indicative of the lack of either PEG8NB homopolymerization or 
gelation due to supramolecular assembly (or threading) between multi-arm PEG and βCD.
The fast thiol-ene gelation using macromers functionalized with norbornene, a strained ene, 
is well-documented in the literature. For example, we have shown that PEG-peptide thiol-
norbornene gelation could be achieved rapidly (gel point ∼ 2-3 seconds) using low PEGNB 
and photoinitiator concentrations (e.g., 4 wt% PEG4NB20kDa with DTT or bis-cysteine 
peptides and 1 mM LAP) 31. On the other hand, Kloxin and colleague designed a radical-
mediated (1.1 mM of LAP) thiol-allylether hydrogel system using 10 wt% of PEG4SH 
(M.W. 20 kDa) with alloc-functionalized peptides and obtained a gel point of about 15 
seconds 25. While both allylether and norbornene react with thiol via a strictly step-growth 
mechanism (i.e., no homopolymerization between the ene groups) 32, the polymerization 
rate of thiol-norbornene is six times faster than that of thiol-allylether due to the unity ratio 
of thiyl radical propagation to chain transfer kinetic parameters (kpSC /kCT) 32. It is worth 
noting that, while thiol-norbornene gelation was one order of magnitude faster than thiol-
allylether gelation, the final gel shear modulus of the former was only about half of the 
latter. This could be explained by the fact that PEG8NB, which was synthesized in house, 
was lower in the degree of functionalization (85%, per 1H NMR) as compared with 
commercially acquired PEG8SH (>95%, per manufacturer's certificate of analysis, 
respectively). Furthermore, since βCD-SH was modified from βCD-AE, it would make 
sense that gels crosslinked by βCD-SH would have a lower degree of crosslinking, and 
hence lower shear modulus, as compared with gels crosslinked by βCD-AE.
CD has been shown to assist the assembly of physical ‘pseudo-polyrotaxane’ hydrogel 
through interactions with PEG or block co-polymers of polypropylene oxide (PPO) and 
polyethylene oxide (PEO) (e.g., Pluronic). Previously, Cooper-White and colleagues 
reported supramolecular gelation of αCD with Pluronic co-polymers and concluded that the 
‘threading’ induced gelation would only occur in the presence of ‘poly-CD’ aggregates, 
which was only apparent at a sufficiently high concentration of CD (at least 50-70 mg/
mL) 33. The gelation in the work presented here was purely based on thiol-ene 
photochemistry since the CD concentrations used in this study were less than 40 mg/mL and 
the fact that no gelation was observed by simply mixing unmodified βCD with PEGNB 
(Figure 2C). Another relevant work reported by Elisseeff and colleagues showed a tunable 
CD/PEG hybrid hydrogel crosslinked by chain-growth photopolymerization. It is worth 
noting that the functionalized βCD motifs were ‘threaded’ onto PEG-diacrylate after 
overnight incubation34. We believe that the threading of CD to PEG chains was minimal, if 
any, since we added βCD into the mixture right before photopolymerization in all 
experiments. Another potential complication is the formation of LAP/βCD complex. We 
performed isocratic HPLC using acetonitrile/phosphate buffer (35/65) containing βCD (0 to 
10 mM) as the mobile phase. While the elution time of LAP shifted slightly (Figure S4A), 
the peaks were not significantly different from each other regardless of βCD concentration 
(Figure S4B). Furthermore, since the gelation was accomplished within 5 minutes, it is 
unlikely that the association between LAP and βCD, if any, would impede light-induced 
initiator breakdown and gelation. If association between LAP and βCD does exist, it would 
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also not be a concern because upon light irradiation the photoinitiators would be photolysed 
into smaller fragments and readily diffuse out from the CD cavity.
Effects of macromer functionality and molecular weight on gelation kinetics
Since thiol-norbornene reaction exhibits faster gelation kinetics than thiol-allylether 
reaction, we evaluated the effects of PEGNB macromer functionality and molecular weight 
on the gelation of CD-based thiol-norbornene hydrogels (Figure 3). PEG4NB (M.W. 20 
kDa, Figure 3A) and PEG8NB (M.W. 40 kDa, Figure 3B) were selected as these two 
macromers provided the same total concentration of norbornene at the same weight 
percentage (i.e., 10 mM at 5 wt%). Note that the molar ratio of norbornene to thiol was 
maintained at one, whereas the concentration of thiol from βCD-SH was determined by 
Ellman's assay (Figure S2). Since the average molecular weight per arm in these two 
macromers was the same (i.e., 5 kDa), the average molecular weight between crosslinks 
( ) of the two was also the same (Eq. 3). This implied that the two sets of hydrogels 
would have the same ideal crosslinking efficiency (Eq. 4). Experimentally, however, we 
found that thiol-norbornene hydrogels cross-linked by PEG4NB (20 kDa) had a slightly 
slower gel point (∼6 seconds) and a lower shear modulus (∼1 kPa) when compared with gels 
crosslinked by PEG8NB (40 kDa) (∼4 seconds and ∼3 kPa). These results was consistent 
with the trend found in previously reported step-growth Michael-type hydrogels 35. 
Theoretically, step-growth hydrogels with the same  (Eq. 3) should have identical mesh 
size (Eq. 4) regardless of the macromer concentration. Experimentally, however, macromer 
with lower functionality formed hydrogel with higher swelling ratio compared with 
macromer with higher functionality 28, 31. The phenomenon was attributed to network 
defects and inefficient cross-linking at lower macromer functionality. We also compared 
gelation kinetics of CD-based thiol-norbornene hydrogels using macromer PEG8NB with 
different molecular weight (Figure 3B & 3C). The gel point of hydrogel cross-linked by 20 
kDa PEG8NB was 2.2–fold faster, and the elastic modulus was 1.5–fold higher, than the gels 
cross-linked by 40 kDa PEG8NB. These results were also expected because of the higher 
molarity of norbornene groups on 20 kDa PEG8NB at equivalent polymer weight content.
Effects of cross-linker on hydrogel properties
After examining the effect of CD-PEG macromer formulations on gelation, we evaluated the 
influence of crosslinker on the physical properties of selective groups of thiol-norbornene 
hydrogels. Three sets of macromers were used: (1) DTT with PEG4NB (labelled as DTT in 
Figure 4), (2) βCD-SH with PEG4NB (labelled as CD-SH), and (3) PEG4SH with βCD-AE 
(labelled as CD-AE). As shown in Figure 4A, the gel fraction was not significantly different 
between the three groups (86 ± 3 %, 79 ± 8 %, and 74 ± 6 % for DTT, CD-SH, and CD-AE 
gel, respectively). However, the DTT gel exhibited the highest equilibrium shear modulus 
when compared with gels crosslinked with CD-SH or CD-AE (Figure 4B, ∼7.1, 3.4, and 2.4 
kPa for DTT, CD-SH and CD-AE gel, respectively). The differences in equilibrium shear 
moduli reflected the variation in network crosslinking density, which was affected by the 
types of thiol (i.e., DTT, CD-SH, or PEG4SH) and ene (i.e., norbornene or allylether) used 
in the formulations 31. The lowest crosslinked CD-AE gels also had highest swelling ratio 
among the three groups (Figure 4D). Interestingly, even though the modulus of DTT gel was 
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higher than that of CD-SH gel (Figure 4B & 4C), the swelling ratio of DTT gel was also 2-
fold higher than that of CD-SH gel (Figure 4D). This result was contradictory to the inverse 
scaling of modulus and swelling ratio in chemically crosslinked hydrogels. A significantly 
lower swelling ratio for CD-SH gel might be a result of higher CD-SH concentration and 
mass (48 mg/mL) required for this formulation. As a comparison, the concentration of DTT 
used was only 1.5 mg/mL. Inclusion of higher content of amphiphilic CD in the gel 
formulations might profoundly impact the ability of these gels to imbibe water.
The step-growth thiol-norbornene hydrogels were known to degrade hydrolytically if ester 
bonds were presence in the PEGNB macromers 31. We evaluated the hydrolytic stability of 
the three groups of thiol-ene hydrogels (i.e., DTT, CD-SH, and CD-AE gel). The hydrolytic 
degradation of these thiol-ene hydrogels in neutral buffer solution (pH 7.4) was not 
significant as the modulus and swelling ratio remained relatively stable over 10 days (Figure 
4C & 4D). We reason that this was because these gels were either highly crosslinked (G′ 
∼7.1 kPa and 3.4 kPa for DTT and CD-SH gel, respectively) or contained no hydrolytically 
labile bonds (e.g., CD-AE thiol-allylether gel). We also conducted an accelerated hydrolysis 
study (Figure S5) by incubating these hydrogels in basic buffer (pH 9). As expected, a 
decline in G′ over time was observed for DTT and CD-SH gels (both crosslinked with 
PEG4NB), indicative of base-catalysed hydrolysis of ester bonds in PEG4NB macromer 
(Figure S5). On the other hand, CD-AE gel remained intact over time (i.e., constant G′) 
since thiol-allylether hydrogels did not contain hydrolytic degradable moieties.
Uptake and release of hydrophobic curcumin from thiol-allylether hydrogels
One potential application of the CD-PEG hydrogel system is to deliver hydrophobic drugs. 
Many anti-inflammatory drugs, such as curcumin 36, are hydrophobic and hence have lower 
bioavailability in vivo. Curcumin has also been a subject of intensive research interest in 
diabetes because of its blood glucose lowering effect 37. Since thiol-norbornene hydrogels 
would be hydrolyzed in basic buffer 31, we chose thiol-allylether hydrogels crosslinked by 
CD-AE and PEG4SH as a model gel system to demonstrate the enhanced uptake and 
sustained release effect of curcumin from CD-PEG hybrid hydrogels. Pure PEG hydrogels 
crosslinked by PEGAE and PEG4SH under the same gelation conditions were used as 
control. The two sets of gels (labeled as PEGAE and CD-AE in Figure 5) were incubated in 
ddH2O suspended with hydrophobic curcumin for 8 hours. As shown in the top panel of 
Figure 5A, hydrogels crosslinked with CD-AE appeared more yellowish when compared to 
hydrogels crosslinked with PEGAE, indicative of higher amount of curcumin (yellow in 
color) uptake due to the presence of chemically crosslinked CD in the gel. Subsequently, 
these gels were immersed in DMSO to completely liberate the curcumin. As shown in the 
bottom panel of Figure 5A, both sets of gels appear transparent and identical, indicating that 
all curcumin were released from the gels. The liberated curcumin was quantified via UV/vis 
absorbance measurement (Figure 5B). Compared to pure PEG hydrogels crosslinked with 
PEGAE and PEG4SH, hydrogels crosslinked with CD-AE were capable of loading twice as 
much curcumin (∼9 and ∼20 μg/gel for PEGAE and CD-AE gel, respectively).
Because the amount of curcumin loading in the control PEGAE gel was much lower than 
that in the CD-AE gel, the release of curcumin from PEGAE hydrogel was barely detectable 
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and it would be difficult to compare the release of curcumin from these two sets of gels. 
Therefore, we used an alkaline solution to dissolve and complex curcumin with βCD 
(curcumin was dissolved in 0.5 N NaOH first, followed by diluting with pH 7.4 PBS). This 
method was used previously to form CD-curcumin complex without affecting the 
association of the two molecules 30. Figure 6A shows that prior to drug loading the two sets 
of gels were equally transparent (panel 1). After drug loading (panel 2), the two sets of thiol-
allylether hydrogels became equally opaque, suggestive of similar curcumin intake. The 
similar amount of curcumin absorbed in the gels were quantified by DMSO treatment as 
described earlier (Figure 6B, 6.6 ± 1.1 and 6.9 ± 0.4 μg/gel for PEGAE and CD-AE gel, 
respectively). The gels were then incubated in buffer solution for curcumin release. 
Significantly more curcumin was released from hydrogels crosslinked by PEGAE than by 
CD-AE (Figure 6C, 85 % and 42 % of curcumin was released from PEGAE and CD-AE 
hydrogels after 10 hours, respectively). Over the course of first 100 hours, a 1.8-fold higher 
amount of curcumin was released from PEGAE-crosslinked gels than from CD-AE 
crosslinked gels (Figure 6C, 87 % and 49 %, respectively\). After the release study, CD-AE 
gel appeared slightly darker than PEGAE gel (Figure 6A, panel 3), suggesting that a higher 
amount of curcumin was still retained in this gel. However, after DMSO treatment for an 
additional 100 hours, the remaining curcumin were completely released from both sets of 
hydrogels (Figure 6C) and the appearances of the gels were similar in color (Figure 6A, 
panel 4).
The increase of curcumin solubility via guest-host interactions with CD is well 
documented 38-40. In our study, CD-AE was employed as both a hydrogel crosslinker and a 
carrier for hydrophobic drug (i.e., curcumin). Compared to thiol-allylether hydrogels 
crosslinked by PEGAE, gels crosslinked by CD-AE accommodated significantly more 
curcumin due to the formation of inclusion complex. The presence of CD/curcumin 
inclusion complex also resulted in delayed/sustained release of curcumin from the CD-AE 
hydrogel. Since all curcumin absorbed in the gel could be liberated by DMSO, we believe 
that the retention of curcumin was purely due to inclusion complex formation but not 
Michael-type reaction occurred between curcumin and nucleophilic thiols in the gels 41,42.
Cytocompatibility of CD-crosslinked thiol-ene hydrogels
Next, we evaluated the cytocompatibility of CD-crosslinked thiol-ene hydrogels using in situ 
encapsulation of pancreatic MIN6 β-cells at a relatively low cell density (2×106 cells/
mL) 24. Thiol-norbornene hydrogels crosslinked by DTT and PEG8NB (M.W. 20 kDa) were 
used as a control group as similar gelation formulation has been shown to be cytocompatible 
for radical-sensitive MIN6 β-cells 23. One day after cell encapsulation, live/dead staining 
was performed and the results show that thiol-norbornene hydrogels crosslinked by CD-SH 
were highly cytocompatible for MIN6 cells (Figure 7A, ∼83 % live cells), while hydrogels 
crosslinked by DTT or by CD-AE contained slightly more dead cells (Figure 7A, ∼72 % and 
73 % live cells for gels crosslinked by DTT and CD-AE, respectively). Regardless of the 
cross-linker used, MIN6 β-cells formed spherical aggregates in all hydrogels 10 days after 
cell encapsulation (Figure 7A, right panel). The average diameters of the spheroids were 
about 18 μm, 26 μm, and 32 μm for hydrogels crosslinked by DTT, CD-SH and CD-AE, 
respectively. We also quantified cell metabolic activity using CellTiter-Glo® (for measuring 
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intracellular ATP content) and AlamarBlue® regent (for measuring cell metabolic activity). 
In DTT or CD-AE crosslinked hydrogels, the intracellular ATP content increased from ∼13 
to 200 pmol of ATP per sample (Figure S7) from day 1 to day 10. The difference between 
DTT and CD-AE crosslinked hydrogels was not significantly on either day 1 or day 10. On 
the other hand, the amount of ATP increased from ∼70 to 390 pmol per sample in hydrogels 
crosslinked by CD-SH (Figure S7). The increased in intracellular ATP was most likely due 
to the cell proliferation and the formation of multi-cell aggregates. Cell proliferation in CD-
PEG hydrogels was verified by Alamarblue® reagent assay (Figure 7B) and the trends were 
consistent with live/dead staining and ATP assay.
Studies have shown that softer matrix and hydrolytic gel degradation promoted the 
phenotype, function, and proliferation of MIN6 βcells in 3D 23, 43. The thiol-norbornene 
hydrogels in the current study were slightly stiffer (Figure 4B) and relatively stable at pH 7.4 
over the course of 10 days (Figure 4C & 4D). Consistent with our published work using 
PEG-based thiol-norbornene hydrogels 31, the hydrolysis rate of CD-PEG hybrid hydrogels 
could be accelerated under basic condition (e.g., pH 9, Figure S5). On the other hand, thiol-
allylether hydrogels remained hydrolytically stable (Figure S5). Compared to CD-SH 
crosslinked hydrogels, the slightly higher initial cell death (Figure 7A to 7C) in DTT-
crosslinked hydrogels might be a result of higher gel stiffness. When we replaced PEG8NB 
with PEG4NB without changing macromer molecular weight (20 kDa) or content (5 wt%), 
the modulus of the hydrogels decreased by half (Figure S7, 3.1 kPa and 1.2 kPa for DTT and 
CD-SH cross-linked gels, respectively). Additional cell encapsulation studies using these 
softer gels showed improved viability of encapsulated MIN6 cells (Figure S9, top panel, 
>98 % viable cells). In addition to gel stiffness, the presence of active radicals could induce 
cellular damage during photo-encapsulation 44. While thiol-allylether hydrogels crosslinked 
by CD-AE were softer than thiol-norbornene hydrogel crosslinked by DTT (Figure 4B, ∼2.4 
kPa and 7.1 kPa for CD-AE and DTT gel, respectively), the viability of MIN6 cells was not 
much higher (Figure 7). We reason that the radical-sensitive MIN6 cells were exposed to 
active radicals for a longer time during the thiol-allylether gelation because of a much lower 
chain transfer kinetic constant, and hence the benefits of a softer gel on cell viability was 
offset by longer exposure of the cells to radical species.
Finally, we evaluated function of encapsulated cells with static glucose stimulated insulin 
secretion (GSIS, Figure 7C). Since the viability of MIN6 cells varied among different 
conditions, the amount of insulin was normalized to the amount of intracellular ATP, which 
scales with cell number at day 10. Compared with thiol-ene hydrogels crosslinked by DTT 
or CD-AE, the secretion of insulin by MIN6 cells encapsulated in thiol-ene hydrogel 
crosslinked by CD-SH was about 3-fold higher than thiol-ene hydrogel crosslinked by DTT 
and CD-AE (Figure 7C, about 0.04 CD-SH, and 0.01 for DTT and βCD-AE). This 
functional assay result also concurs with the notion that softer gel matrix promotes 
phenotype of insulin secreting cells.
Conclusion
In summary, we have synthesized step-growth thiol-ene photopolymerized hydrogel using 
derivatives of βCD and PEG. We found that thiol-norbornene hydrogels crosslinked by CD-
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SH and PEGNB exhibited faster gelation kinetics and higher crosslinking efficiency when 
comparing with thiol-allylether hydrogels crosslinked by PEGSH and CD-AE. Furthermore, 
the gelation kinetics of thiol-norbornene depended highly on the functionality of macromer 
used. In addition, CD/PEG hydrogels afforded higher loading, as well as prolonged and 
sustained delivery, of hydrophobic curcumin. The results of live/dead staining, cell viability 
assay, and GSIS demonstrated that cell viability was maintained in these hydrogels, but in 
some cases affected by hydrogel properties (e.g., stiffness). Future work will focus on 
utilizing this CD-based radical-mediated thiol-ene photopolymerized hydrogel as a delivery 
vehicle of hydrophobic biomolecules.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
(A) Schematics of βCD modifications. (i) NaH, DMF, room temperature; (ii) allylbromide, 
DMF, room temperature; (iii) thioacetic acid, I-2959, UV (365 nm, 10 mW/cm2), 30 min; 
(iv) sodium hydroxide (aq.), followed by neutralization with hydrogen chloride. 1H NMR of 
(B) βCD, (C) βCD-AE, and (D) βCD-SH (dissolved in (CD3)2SO).
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Figure 2. 
(A) Scheme of light and radical mediated thiol-allylether gelation. (B) In situ 
photorheometry of thiol-allylether photopolymerization (G′: storage modulus; G″: loss 
modulus) between PEG8SH and βCD-AE. (C) In situ photorheometry of solution containing 
PEG8SH and βCD. (D) Scheme of light and radical mediated thiol-norbornene gelation. (E) 
In situ photorheometry of thiol-norbornene photopolymerization PEG8NB and βCD-SH. (F) 
In situ photorheometry of solution containing PEG8NB and βCD (5 wt% PEG8SH or 
PEG8NB, 24 mg/mL of βCD-AE or βCD-SH, 1 mM LAP). Light (365 nm, 10 mW/cm2) 
was turned on at 30 seconds (dotted line). N = 3, error bars were omitted for clarity.
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Figure 3. 
In situ photorheometry of thiol-ene hydrogels crosslinked by βCD-SH and (A) PEG4NB (20 
kDa), (B) PEG8NB (40 kDa) or (C) PEG8NB (20 kDa). (5 wt% PEGNB, [thiol] = 
[norbornene], 1 mM LAP). Light (365 nm, 10 mW/cm2) was turned on at 30 seconds (dotted 
line). N = 3, error bars were omitted for clarity.
Shih and Lin Page 18
Biomacromolecules. Author manuscript; available in PMC 2017 May 31.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 4. 
Effect of crosslinker on (A) gel fraction, (B) elastic modulus at equilibrium gel swelling, (C) 
shear modulus as a function of time, and (D) swelling ratio as a function of time. Asterisks 
indicate statistical significance (*p < 0.05, 5 wt% 20 kDa PEG8SH or PEG8NB, 1 mM LAP, 
365 nm light, intensity at 5 mW/cm2, mean ± SD, N = 3).
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Figure 5. 
(A) Photographs of thiol-allylether hydrogels incubated in curcumin suspended ddH2O for 8 
hours (top) and after DMSO-treatment (bottom). (B) Curcumin uptake in hydrogels formed 
by 5 wt% PEG8SH with 3.4 kDa of PEGAE or 24 mg/mL βCD-AE (1 mM LAP, 365 nm 
light at 10 mW/cm2).
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Figure 6. 
(A) Photographs of thiol-allylether hydrogels: (1) immediately after photopolymerization, 
(2) after incubating in curcumin solution for 36 hours, (3) after 100 hours of release in pH 
7.4 PBS, and (4) after an additional 100 hours of release in DMSO (scale: 5 mm). (B) Effect 
of crosslinker on curcumin uptake in the gel. (C) Curcumin release from thiol-allylether 
hydrogel formed by 5 wt% PEG8SH with 3.4 kDa of PEGAE or 24 mg/mL βCD-AE (1 mM 
LAP, 365 nm light at 10 mW/cm2).
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Figure 7. 
Effect of crosslinker on the cytocompatibility of thiol-ene hydrogels on MIN6 β-cells. (A) 
Representative confocal z-stack images of MIN6 cells stained with live/dead staining kit on 
day 1 and day 10. MIN6 cells were encapsulated (2×106 cells/mL) in thiol-ene hydrogels 
crosslinked by DTT, CD-SH or CD-AE. (B) Cells viability as assessed by Alamarblue® 
reagent. (C) Normalized insulin secretion. All gel formulations contained 5 wt% 20 kDa 
PEG8SH or PEG8NB, 1 mM LAP, and 365 nm light at 5 mW/cm2 (Scales: 100 μm).
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